Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) [Phase 4]

View source ↗

Summary

Phase 4 trial status update for ASSENT 4 PCI evaluating tenecteplase with unfractionated heparin before PCI versus standard primary PCI in acute myocardial infa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• TNKASE (tenecteplase)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myocardial Infarction | Phase 4 | Status: TERMINATED